正在加载图片...
Part 7.2: Management of Cardiac Arrest V-65 21. Prengel Aw, Rembecki M, Wenzel V, Steinbach G. A comparison of the 48. Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri R. Pine ndotracheal tube and the laryngeal mask airway as a route for end increases the severity of postresuscitation myocardial dysfunction. M平 akelstein MS. Mandell GA, Salzman SK4.图W时 MY, Blake HC, McGeorge FT, Buderer NM. test. crit care med 19o4:22:1174-1180 g delivery. Pediatr Emerg Care. 1992: 8: 0. Lindner KH, Ahnefeld FW. Prengel Aw. Comparison of standard and Efrati O, Lotan D, Barzilay Z Scand.1991:35:253-256 aret G. Is endotracheal adrenaline deleterious because of the beta 23.mm2图 otan D. Berkovitch Endotracheal epinephrin 52. Stidy Group. N Engl J Med. 1992: 327: 1051-10% 52. Stiell IG. Hebert PC, Weitzman BN. Wells GA, Raman S. Stark RM rten A, Man- lay Z, Paret arinc an es n Med igg2 3 2: 04g-dss epinephrine in aduit 27. Elizn. 2003: 59: 117_esponse and haemodynamic effect in dogs. Resusci 53. Callaham M. Madsen CD. Barton Cw. Saunders CE. Pointer J. A Ben-Abraham R, Manisterski Y, Barak A. Efrati O. Lotan D, ard-dose epinephrine in prehospital cardiac arrest. JAMA. 1992: 268 beta blockade in a o71_276 beta blockade bestow any benefi 54 wilson w, Kobilski S, Scribante J, Lee C, Kraus P, Cooper J. 28. Niemann JT, Stratton SJ, Cruz B, Lewis R. Endotracheal drug adminis- diopulmonary resuscitation: a double-blind randomised trial. Anaesth 55. Choux C. Gueugniaud PY, Barbieux A. Pham E Lae C. Dubien PY, Petit eling BJ, Hornchen U, Kulka P. Suhling B, 56. Sherman BW, Munger MA, Foulke GE, Rutherford WF, Panacek EA High-dose versus standard-dose epinephrine treatment J. Stoeckel H. Eichelkraut tation ergnion M, Petit P, Carli P. A compa of repeated high 31. Naganobu K, Hasebe Y, Uchiyama Y, Hagio M, Ogawa H A comparison as9pLatoturopean Epinephrine Study Group. N Engl /Med.1998: 339 nest analg.200091:317-321. 58. Oyama H, Suzuki Y, Satoh S, Kajita Y, Takayasu M. Shibuya M, M so aid oky khn strdhgse ncr reb. eons per p P93325 er H. Hetzel WD. Ahnefe wy GA, Ou no Cw. Taren DL. Moon TE. Influence of d therapy on ventricular defibrillation in dogs. Crit Care Med. 1980: 8 157-163 60. Lindner KH. Dirks B Strg) 992: 77: 662-668 hmenger hu. prengel aw. Lindner IM. Lurie 34. Wik L, Hansen TB, Fylling F. Steen T, Vaagenes P, Auestad BH, Steen with ith out-of-hospital ventricular fibrillation: a randomized trial 61. Lindner KH, Prengel Aw, Brinkmann A Strohmenger HU, Lindner IM. AMA.2003:289:1389-1 35. American Heart Association in collaboration with the International liaison ommittee on Resuscitation Guidelines 2000 for Car ation and Emergency Cardiovascular Care: International Consensus on 6. Martens PR, Russell JK. Wolcke B. Paschen H, Kuisma M. Gliner BE 63. Morris DC. Der BE, Grzybowski M, Martin GB, Rivers EP Weaver WD. Bossaert L, Chamberlain D Wortsman J, Amico JA. Vasopressin can cardiac Arrest study: defibrillation waveform effects. Resuscitation. pressure during human cardiopulmonary resuscitation. Acad Emerg Med 01:49:233-243 37. Yu T, Weil MH, Tang W. Sun S, Klouche K, Povoas H, Bisera J. Adverse 64. Stiell IG. Hebert PC. Wells GA. Vandemheen KL, Tang AS, Higginson compression during automated defibrin- I I. Mason s. Klass Eftestol T, wik L, Sunde K, Steen PA. Effects of cardiopulmonary resus- 65. Wenzel V. Krismer AC. Amtz HR Sitter H, Stadlbauer KH, Lindner KH. 3 ea ing out-of-hospital cardiac arrest. Circulation. 2004: 1 10:10-15.cess resuscitation. N Engl J Med. 2004: 350: 105-113 hospital cardio- 66. Aung K, Htay pres a systematic review and tients with hospital cardiac arrest Circulation.2000102:1523-1529 67. Guyette FX, Guimond GE, Hostler D, Callaway CW. Vasopressin admin- 40. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial com rdiac arest res ss ted with a retum of a pulse in Bh(CD.k102103202d obability 8. Stueven HA, Tonsfeldt DJ, Thompson BM, Whitcomb J, 41. Yakaitis of a and B Aprahamian C. Atropine in asystole: human studies. Ann Emerg Med. 69. Brown DC. Lewis Aj. Cril iedermeyer E, Rogers MC, Traystman R, Weisfeldt ML Mechanisms by hich epinephrine augments cerebral and myocardial perfusion during 1979: 8: 448-p52mpalheaey JM. Asystole and its treatment: the possible 70. Coon GA, Clinton JE, Ruiz E. Use of atropine for bradyasystolic pre- 71. DeBehnke DJ, Swart GL, Spreng D, Aufderheide TP. Standard and higher oses of atropine in a canine model of pulseless electrical activity. Acad 72. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahr GA. A randomized, blinded trial of high-dose epinephrine P, Ewy bruch CE. Hallstrom AP, Murray WA. Olsufka M. Walsh T. Amiod epinephrine in a swine model of pediatric asphyxial itation after out-of-hospital cardiac arrest due to ventri arrest. Crit Care Med. 1996: 24: 16 ardial 73. Dorian P Cass D, Schwartz B, Cooper R, Gelaznikas R. Barr A. Amiod- CG. Effect of standard-dose versus high-dose epinephrine on myoca fibrillation and closed-ck NEr 346: 884r shock-resistant ventricular fibril- 46. Hormchen U, Lussi C, Schuttler J. Potential risks of high-dose epinephrine 74. Skrifvars MB, Kuisma M, Boyd J, Maatta T, Repo J, Rosenberg Pl or resuscitation from ventricular fibrillation in a porcine model. JCar- thorac Vasc Anesth. 1993- 7. 1 75. Pe-hospital cardiac arrest. Acta Anaesthesiol Scand. 2004: 48: 582-587. rma J. Lewis R. Treatment 76. Levine JH. Massumi A. Scheinman MM, Winkle RA, Platia EV. Chilso rine and CPR preceding countershock. Circulation. 1992: 85: 281-2 A, Gomes A, Woosley RL Intravenous amiodarone for recurrent sus-21. Prengel AW, Rembecki M, Wenzel V, Steinbach G. A comparison of the endotracheal tube and the laryngeal mask airway as a route for endobronchial lidocaine administration. Anesth Analg. 2001;92:1505–1509. 22. Jasani MS, Nadkarni VM, Finkelstein MS, Mandell GA, Salzman SK, Norman ME. Effects of different techniques of endotracheal epinephrine administration in pediatric porcine hypoxic-hypercarbic cardiopulmonary arrest. Crit Care Med. 1994;22:1174–1180. 23. Johnston C. Endotracheal drug delivery. Pediatr Emerg Care. 1992;8: 94–97. 24. Vaknin Z, Manisterski Y, Ben-Abraham R, Efrati O, Lotan D, Barzilay Z, Paret G. Is endotracheal adrenaline deleterious because of the beta adrenergic effect? Anesth Analg. 2001;92:1408–1412. 25. Manisterski Y, Vaknin Z, Ben-Abraham R, Efrati O, Lotan D, Berkovitch M, Barak A, Barzilay Z, Paret G. Endotracheal epinephrine: a call for larger doses. Anesth Analg. 2002;95:1037–1041. 26. Efrati O, Ben-Abraham R, Barak A, Modan-Moses D, Augarten A, Manisterski Y, Barzilay Z, Paret G. Endobronchial adrenaline: should it be reconsidered? Dose response and haemodynamic effect in dogs. Resuscitation. 2003;59:117–122. 27. Elizur A, Ben-Abraham R, Manisterski Y, Barak A, Efrati O, Lotan D, Barzilay Z, Paret G. Tracheal epinephrine or norepinephrine preceded by beta blockade in a dog model: can beta blockade bestow any benefits? Resuscitation. 2003;59:271–276. 28. Niemann JT, Stratton SJ, Cruz B, Lewis RJ. Endotracheal drug administration during out-of-hospital resuscitation: where are the survivors? Resuscitation. 2002;53:153–157. 29. Schuttler J, Bartsch A, Ebeling BJ, Hornchen U, Kulka P, Suhling B, Stoeckel H. [Endobronchial administration of adrenaline in preclinical cardiopulmonary resuscitation.] Anasth Intensivther Notfallmed. 1987;22: 63–68. 30. Hornchen U, Schuttler J, Stoeckel H, Eichelkraut W, Hahn N. Endobronchial instillation of epinephrine during cardiopulmonary resuscitation. Crit Care Med. 1987;15:1037–1039. 31. Naganobu K, Hasebe Y, Uchiyama Y, Hagio M, Ogawa H. A comparison of distilled water and normal saline as diluents for endobronchial administration of epinephrine in the dog. Anesth Analg. 2000;91:317–321. 32. Cobb LA, Fahrenbruch CE, Walsh TR, Copass MK, Olsufka M, Breskin M, Hallstrom AP. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA. 1999;281:1182–1188. 33. Yakaitis RW, Ewy GA, Otto CW, Taren DL, Moon TE. Influence of time and therapy on ventricular defibrillation in dogs. Crit Care Med. 1980;8: 157–163. 34. Wik L, Hansen TB, Fylling F, Steen T, Vaagenes P, Auestad BH, Steen PA. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial. JAMA. 2003;289:1389–1395. 35. American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Circulation. 2000;102:I1–I384. 36. Martens PR, Russell JK, Wolcke B, Paschen H, Kuisma M, Gliner BE, Weaver WD, Bossaert L, Chamberlain D, Schneider T. Optimal Response to Cardiac Arrest study: defibrillation waveform effects. Resuscitation. 2001;49:233–243. 37. Yu T, Weil MH, Tang W, Sun S, Klouche K, Povoas H, Bisera J. Adverse outcomes of interrupted precordial compression during automated defibrillation. Circulation. 2002;106:368–372. 38. Eftestol T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation on predictors of ventricular fibrillation defibrillation success during out-of-hospital cardiac arrest. Circulation. 2004;110:10–15. 39. Eftestol T, Sunde K, Aase SO, Husoy JH, Steen PA. Predicting outcome of defibrillation by spectral characterization and nonparametric classification of ventricular fibrillation in patients with out-of-hospital cardiac arrest. Circulation. 2000;102:1523–1529. 40. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions on the calculated probability of defibrillation success during out-of-hospital cardiac arrest. Circulation. 2002;105:2270–2273. 41. Yakaitis RW, Otto CW, Blitt CD. Relative importance of and adrenergic receptors during resuscitation. Crit Care Med. 1979;7:293–296. 42. Michael JR, Guerci AD, Koehler RC, Shi AY, Tsitlik J, Chandra N, Niedermeyer E, Rogers MC, Traystman RJ, Weisfeldt ML. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation. 1984;69:822–835. 43. Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation. 1988;78:382–389. 44. Berg RA, Otto CW, Kern KB, Hilwig RW, Sanders AB, Henry CP, Ewy GA. A randomized, blinded trial of high-dose epinephrine versus standard-dose epinephrine in a swine model of pediatric asphyxial cardiac arrest. Crit Care Med. 1996;24:1695–1700. 45. Hoekstra JW, Griffith R, Kelley R, Cody RJ, Lewis D, Scheatzle M, Brown CG. Effect of standard-dose versus high-dose epinephrine on myocardial high-energy phosphates during ventricular fibrillation and closed-chest CPR. Ann Emerg Med. 1993;22:1385–1391. 46. Hornchen U, Lussi C, Schuttler J. Potential risks of high-dose epinephrine for resuscitation from ventricular fibrillation in a porcine model. J Cardiothorac Vasc Anesth. 1993;7:184–187. 47. Niemann JT, Cairns CB, Sharma J, Lewis RJ. Treatment of prolonged ventricular fibrillation: immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation. 1992;85:281–287. 48. Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation. 1995;92:3089–3093. 49. Rivers EP, Wortsman J, Rady MY, Blake HC, McGeorge FT, Buderer NM. The effect of the total cumulative epinephrine dose administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest. 1994;106:1499–1507. 50. Lindner KH, Ahnefeld FW, Prengel AW. Comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiol Scand. 1991;35:253–256. 51. Brown CG, Martin DR, Pepe PE, Stueven H, Cummins RO, Gonzalez E, Jastremski M. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital: the Multicenter High-Dose Epinephrine Study Group. N Engl J Med. 1992;327:1051–1055. 52. Stiell IG, Hebert PC, Weitzman BN, Wells GA, Raman S, Stark RM, Higginson LA, Ahuja J, Dickinson GE. High-dose epinephrine in adult cardiac arrest. N Engl J Med. 1992;327:1045–1050. 53. Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA. 1992;268: 2667–2672. 54. Lipman J, Wilson W, Kobilski S, Scribante J, Lee C, Kraus P, Cooper J, Barr J, Moyes D. High-dose adrenaline in adult in-hospital asystolic cardiopulmonary resuscitation: a double-blind randomised trial. Anaesth Intensive Care. 1993;21:192–196. 55. Choux C, Gueugniaud PY, Barbieux A, Pham E, Lae C, Dubien PY, Petit P. Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation. 1995;29:3–9. 56. Sherman BW, Munger MA, Foulke GE, Rutherford WF, Panacek EA. High-dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy. 1997;17:242–247. 57. Gueugniaud PY, Mols P, Goldstein P, Pham E, Dubien PY, Deweerdt C, Vergnion M, Petit P, Carli P. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med. 1998;339: 1595–1601. 58. Oyama H, Suzuki Y, Satoh S, Kajita Y, Takayasu M, Shibuya M, Sugita K. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J Cereb Blood Flow Metab. 1993;13:285–290. 59. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology. 1992;77:662–668. 60. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. 1997;349:535–537. 61. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med. 1996;124:1061–1064. 62. Mann K, Berg RA, Nadkarni V. Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series. Resuscitation. 2002;52: 149–156. 63. Morris DC, Dereczyk BE, Grzybowski M, Martin GB, Rivers EP, Wortsman J, Amico JA. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med. 1997;4:878–883. 64. Stiell IG, Hebert PC, Wells GA, Vandemheen KL, Tang AS, Higginson LA, Dreyer JF, Clement C, Battram E, Watpool I, Mason S, Klassen T, Weitzman BN. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet. 2001;358:105–109. 65. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350:105–113. 66. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch Intern Med. 2005;165:17–24. 67. Guyette FX, Guimond GE, Hostler D, Callaway CW. Vasopressin administered with epinephrine is associated with a return of a pulse in out-ofhospital cardiac arrest. Resuscitation. 2004;63:277–282. 68. Stueven HA, Tonsfeldt DJ, Thompson BM, Whitcomb J, Kastenson E, Aprahamian C. Atropine in asystole: human studies. Ann Emerg Med. 1984;13:815–817. 69. Brown DC, Lewis AJ, Criley JM. Asystole and its treatment: the possible role of the parasympathetic nervous system in cardiac arrest. JACEP. 1979;8:448–452. 70. Coon GA, Clinton JE, Ruiz E. Use of atropine for bradyasystolic prehospital cardiac arrest. Ann Emerg Med. 1981;10:462–467. 71. DeBehnke DJ, Swart GL, Spreng D, Aufderheide TP. Standard and higher doses of atropine in a canine model of pulseless electrical activity. Acad Emerg Med. 1995;2:1034–1041. 72. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341:871–878. 73. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346:884–890. 74. Skrifvars MB, Kuisma M, Boyd J, Maatta T, Repo J, Rosenberg PH, Castren M. The use of undiluted amiodarone in the management of outof-hospital cardiac arrest. Acta Anaesthesiol Scand. 2004;48:582–587. 75. Petrovic T, Adnet F, Lapandry C. Successful resuscitation of ventricular fibrillation after low-dose amiodarone. Ann Emerg Med. 1998;32:518–519. 76. Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes A, Woosley RL. Intravenous amiodarone for recurrent susPart 7.2: Management of Cardiac Arrest IV-65